NasdaqCM - Nasdaq Real Time Price USD

NeoGenomics, Inc. (NEO)

Compare
14.77
-3.84
(-20.63%)
At close: January 10 at 4:00:01 PM EST
14.90
+0.13
+(0.88%)
After hours: January 10 at 7:15:12 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
644,118.00
591,643.00
509,728.00
484,329.00
444,448.00
Cost of Revenue
363,687.00
347,039.00
321,832.00
297,269.00
258,555.00
Gross Profit
280,431.00
244,604.00
187,896.00
187,060.00
185,893.00
Operating Expense
366,554.00
341,252.00
341,003.00
305,814.00
199,885.00
Operating Income
-86,123.00
-96,648.00
-153,107.00
-118,754.00
-13,992.00
Net Non Operating Interest Income Expense
12,270.00
9,995.00
-1,506.00
-5,082.00
-7,019.00
Other Income Expense
-5,980.00
-10,444.00
-4,729.00
108,761.00
6,955.00
Pretax Income
-79,833.00
-97,097.00
-159,342.00
-15,075.00
-14,056.00
Tax Provision
-2,105.00
-9,129.00
-15,092.00
-6,728.00
-18,228.00
Net Income Common Stockholders
-77,728.00
-87,968.00
-144,250.00
-8,347.00
4,172.00
Diluted NI Available to Com Stockholders
-77,728.00
-87,968.00
-144,250.00
-8,347.00
4,172.00
Basic EPS
-0.61
-0.70
-1.16
-0.07
0.04
Diluted EPS
-0.61
-0.70
-1.16
-0.07
0.04
Basic Average Shares
126,351.75
125,502.00
124,217.00
119,962.00
108,579.00
Diluted Average Shares
126,351.75
125,502.00
124,217.00
119,962.00
111,794.00
Total Operating Income as Reported
-92,279.00
-107,736.00
-157,623.00
-118,754.00
-13,992.00
Total Expenses
730,241.00
688,291.00
662,835.00
603,083.00
458,440.00
Net Income from Continuing & Discontinued Operation
-77,728.00
-87,968.00
-144,250.00
-8,347.00
4,172.00
Normalized Income
-71,734.32
-77,922.27
-140,161.21
-8,347.00
7,753.38
Interest Income
18,944.00
16,902.00
6,075.00
3,138.00
--
Interest Expense
6,674.00
6,907.00
7,581.00
8,220.00
7,019.00
Net Interest Income
12,270.00
9,995.00
-1,506.00
-5,082.00
-7,019.00
EBIT
-73,159.00
-90,190.00
-151,761.00
-6,855.00
-7,037.00
EBITDA
-439.00
-17,607.00
-82,331.00
46,497.00
28,684.00
Reconciled Cost of Revenue
363,687.00
347,039.00
321,832.00
297,269.00
258,555.00
Reconciled Depreciation
72,720.00
72,583.00
69,430.00
53,352.00
35,721.00
Net Income from Continuing Operation Net Minority Interest
-77,728.00
-87,968.00
-144,250.00
-8,347.00
4,172.00
Total Unusual Items Excluding Goodwill
-6,156.00
-11,088.00
-4,516.00
--
-4,906.00
Total Unusual Items
-6,156.00
-11,088.00
-4,516.00
--
-4,906.00
Normalized EBITDA
5,717.00
-6,519.00
-77,815.00
46,497.00
33,590.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-162.32
-1,042.27
-427.21
--
-1,324.62
12/31/2020 - 3/16/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NEOG Neogen Corporation
12.36
-5.43%
 
VCYT Veracyte, Inc.
41.54
-5.12%
 
GH Guardant Health, Inc.
36.71
+0.31%
 
CSTL Castle Biosciences, Inc.
30.25
-7.55%
 
EXAS Exact Sciences Corporation
56.50
-0.32%
 
NTRA Natera, Inc.
175.00
-0.91%
 
TWST Twist Bioscience Corporation
43.60
-3.37%
 
PSNL Personalis, Inc.
5.59
-0.18%
 
ICLR ICON Public Limited Company
218.22
-0.51%
 
GRAL GRAIL, Inc.
17.73
+0.40%